The Solesis Difference
Your Strategic Partner for Innovation
Our long-standing partnerships with leading healthcare innovators have helped teams accelerate time-to-market with optimal applied biomaterial solutions across key therapeutic areas, including vascular, general surgery, and drug delivery and biopharmaceutical manufacturing.
Strategic Collaboration for Transformative Results
At Solesis, we empower healthcare developers to accelerate their innovation. Over the last 50+ years, we’ve delivered millions of biomaterial solutions to support commercial and clinical-stage therapies.
With a portfolio of pre-validated and fully customizable materials—including 3D textiles, polymer blends, and bioresorbable materials—built to your unique specifications, we offer flexible, collaborative partnership models to help you develop the right component for your medical device or therapy.
Choose Your Journey with Us
A Collaborative Approach to Success
MedTech Innovators
MedTech teams developing components for medical devices and delivery systems can leverage our advanced medical textiles and polymers to overcome complex challenges across implantable device delivery. Our end-to-end support begins with developing components for scalable manufacturing, to efficiently move your medical device from idea to market. We also support innovators in their pursuit of next-generation biomaterials through our biocompatible, bioresorbable platform, Hydralese®MT. Start a development project with us today.
Pharma Innovators
Pharma teams developing long-acting, implantable devices can rely on Hydralese®Rx—a biodegradable polymer platform engineered for the controlled release of APIs and biologics. With excellent biocompatibility, tunable degradation and release profiles, it supports the development of complex drug delivery systems. Talk to us about developing your drug delivery device using HydraleseRx.
Life Sciences Organizations
Life Sciences organizations seeking optimal single-use solutions from early-stage process development through successful manufacturing transfer and commercialization for advanced therapy processes, such as cell therapies, gene therapies, and monoclonal antibodies, among others. From a portfolio of off-the-shelf products to developing fully custom designs, our team ensures you have the solutions required for biological fluid handling, cell growth, and cryopreservation to support a successful biomanufacturing process. Learn more about how our Charter Medical team can support your process optimization.
Partners Seeking Technology Licensing Opportunities
Organizations interested in licensing next-generation technologies can partner with us to accelerate pharmaceutical innovation. Our Hydralese®Tx is ready for collaborative development into a commercial transfection product capable of enabling future breakthroughs in genetic medicine. Contact us about being a part of our next-gen solutions.